FDA Approves Final Trials of MDMA as Post Traumatic Stress Disorder Treatment

On 29 November 2016, the Food and Drug Administration opened the door to new exploration of treating post-traumatic stress disorder using the mood-altering drug methylenedioxymethamphetamine (usually shortened to MDMA and known colloquially as Ecstasy or Molly). Discussions of the alternative therapy dated back to at least 2001, and research published since shows potentially strong gains… Read More »